Poly Medicure Limited (Polymed), a global leader in medical devices, has announced that it has received Medical Device Regulation (MDR) certification for 54 of its products, catering to a diverse range of medical specialties, such as Infusion Therapy, Vascular Access, Renal Care, Urology, Surgery & Wound Care, Transfusion Systems, Anaesthesia & Respiratory Care, Gastroenterology, and Diagnostics.
The MDR certification reaƯirms that these products meet the highest safety, quality, and regulatory standards set by the European Union. This achievement marks a significant milestone for Polymed, reinforcing its commitment to providing innovative and safe medical solutions to healthcare professionals worldwide.
Commenting on this achievement, Mr. Rishi Baid, Joint Managing Director of Poly Medicure, said, "Polymed has been the largest exporter of consumable medical devices for over a decade now. The MDR certification demonstrates that our products not only meet but exceed the most stringent safety and quality standards. We are steadfast in our commitment to these principles, which are at the core of our growth and success. With Europe already contributing half of our export revenue, this certification will further strengthen our presence and reputation in the European market. It is a testament to our focus on quality, innovation, and customer satisfaction."
This certification reinforces Polymed's position as a trusted global leader in the medical device industry, with an unwavering focus on quality, safety, and continuous innovation.
Shares of Poly Medicure Limited was last trading in BSE at Rs. 2303.10 as compared to the previous close of Rs. 2281.35. The total number of shares traded during the day was 1830 in over 399 trades.
The stock hit an intraday high of Rs. 2313.00 and intraday low of 2259.25. The net turnover during the day was Rs. 4188942.00.